Back to Type 2 Diabetes
NCT05814107
NCT05814107
Who may be able to join
Who might be able to join this trial:
- You are between 18 and 65 years old
- Your BMI (a measure of body weight relative to height) is between 25 and 40
- Your weight has been stable for the past two months
- For one specific part of the trial (Part 3 only): you have been diagnosed with Type 2 Diabetes
- For that same part (Part 3 only): your HbA1c level (a blood test that shows average blood sugar over time) is between 7.0% and 10.0% (confirm with trial site)
Who may not be able to join:
- You have a history of serious medical conditions or cancer
- You have high blood pressure that cannot be controlled
- You have had issues with alcohol or drug addiction within the past year
- You are currently taking part in, or have recently taken part in, another clinical trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Trial details
Status
Completed
Phase
Phase 1
Sponsor
Carmot Australia First Pty Ltd
Registry
clinicaltrials_gov
Start date
9 May 2023
Est. completion
7 November 2025
Where this trial is recruiting
🇦🇺 Australia
🇲🇽 Mexico
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Incidence of Treatment-Emergent Adverse Events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.